FDA enforcement comparison

Medline Industries, LP vs Suzhou Suncadia Biopharmaceuticals Co., Ltd.: FDA Enforcement Comparison

Medline Industries, LP has been the subject of 242 FDA enforcement/approval records tracked by Argus HQ, compared to 1 for Suzhou Suncadia Biopharmaceuticals Co., Ltd..

Medline Industries, LP: 0 warning letters, 242 recalls, 0 approval records, 0 Form 483s.

Suzhou Suncadia Biopharmaceuticals Co., Ltd.: 0 warning letters, 0 recalls, 0 approval records, 1 Form 483.

Side by side

Medline Industries, LP — Warning letters0
Suzhou Suncadia Biopharmaceuticals Co., Ltd. — Warning letters0
Medline Industries, LP — Recalls242
Suzhou Suncadia Biopharmaceuticals Co., Ltd. — Recalls0
Medline Industries, LP — Approval records0
Suzhou Suncadia Biopharmaceuticals Co., Ltd. — Approval records0
Medline Industries, LP — Form 483s0
Suzhou Suncadia Biopharmaceuticals Co., Ltd. — Form 483s1

Timeline

Medline Industries, LP

Most recent FDA action: July 1, 2026

Full history →

Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Most recent FDA action: January 6, 2025

Full history →

Cite this comparison

Pre-formatted for a story, footnote, or reference list:

"Medline Industries, LP vs Suzhou Suncadia Biopharmaceuticals Co., Ltd.: FDA Enforcement Comparison." Argus HQ, accessed July 13, 2026. https://argushq.ai/compare/medline-industries-lp-vs-suzhou-suncadia-biopharmaceuticals-co-ltd

Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗